Newsroom - TRB Chemedica International

Filters

MDR approved, Ostenil products for joint health

How TRB is proactively addressing the new European Medical Devices Regulation (MDR)

Learn More

TRB Chemedica International S.A. and InnoMedica Holding AG enter in a long-term relationship regarding the production of GM1 (monosialotetrahexosylganglioside) and its development as a liposomal formulation under the trade name Talineuren®

TRB Chemedica announces a collaboration with InnoMedica to develop liposomal GM1

Learn More

Hyaluronic Acid injection and cost TRB Chemedica

Are more expensive products any more clinically effective?

Learn More

european-business-trb-chemedica-interview

Read the European Business magazine interviews of Alessandro di Napoli

Learn More

Presentation of DISSCO results at the WCO-IOF-ESCEO congress in Paris (past event)

Learn More

You are about to leave the TRB corporate website. This link will take you to a local TRB website. Medical practices and regulations can be different from one country to another.

As a result, the medical information provided in the site which you are going to visit may not be appropriate for product use in your country.

CONTINUE